Radiotherapy in relation to temozolomide: Subgroup analysis of molecular markers of the randomized phase III study by the EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033) in patients with a high risk low-grade glioma.
Year: 2015
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Brigitta G. Baumert, Monika E. Hegi, Warren P. Mason, Gail Ryan, Khê Hoang-Xuan, Jacoline E Bromberg, Martin J. Van Den Bent, Mohamed Ben Hassel, Christine Marosi, Alba Ariela Brandes, Jeremy Rees, Andreas von Deimling, Christian Hartmann, Johan M Kros, Denis A. Lacombe, Thierry Gorlia, David Capper, Sebastian Kurscheid, Roger Stupp
Institutions: University of Bonn, University Hospital Bonn, Centre Hospitalier Universitaire Vaudois, University Health Network, Princess Margaret Cancer Centre, Peter MacCallum Cancer Centre, Assistance Publique – Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Erasmus MC, Daniel den Hoed Kliniek, Centre Eugène Marquis, University of Vienna, Azienda USL di Bologna, National Hospital for Neurology and Neurosurgery, German Cancer Research Center, Heidelberg University, Medizinische Hochschule Hannover, Erasmus MC Cancer Institute, European Organisation for Research and Treatment of Cancer, European Organisation for Research and Treatment of Cancer, University Hospital Heidelberg, University of Zurich, University Hospital Zurich
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2473259836